Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide for MDS after HMA failure
NCT01673308Phase 2Unknown
- Sponsor
- Ulsan University Hospital
- Start
- Aug 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in myelodysplastic syndrome (MDS), sponsored by Ulsan University Hospital. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01673308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673308.